KL2 scholar Elysia Alvarez is the first author of a study published on December 3 in Lancet Oncology. The manuscript presents an analysis of results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. With a focus on the outcome of disability-adjusted life-years (DALYs), the study informs global cancer control measures in adolescents and young adults (aged 15-39 years).
Alvarez, assistant professor of clinical pediatrics with UC Davis Health, is dedicated to improving survival outcomes in adolescents and young adults with cancer. Studies focusing on incidence and mortality, while important, do not always capture the entire impact of a disease on a population. This study, focused on disability-adjusted life year burden, allows for a comprehensive analysis of the impact of cancer in the young population as students or starting their careers and families. In addition to this work, Alvarez is exploring the experience of adolescents and young adults with cancer in Latin America and the barriers they face to care in hopes of improving outcomes in this unique population.
- University of California Davis, CTSA Program Hub
- KL2
- Cancer Research
Organization
University Of California Davis
CTSA Program In Action Goals
Goal 1: Train and Cultivate the Translational Science Workforce
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan